Stockreport

Roivant Sciences benefits from Arbutus patent win over Moderna; shares up 37% [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Roivant Sciences benefits from Arbutus patent win over Moderna; shares up 37% [Read more]